# COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study

> **NCT04864548** · PHASE1 · UNKNOWN · sponsor: **University of Oxford** · enrollment: 132 (estimated)

## Conditions studied

- Coronavirus

## Interventions

- **BIOLOGICAL:** SARS-CoV-2 virus

## Key facts

- **NCT ID:** NCT04864548
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-05-27
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2023-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04864548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04864548, "COV-CHIM01: SARS-CoV-2 (COVID-19) Dose Finding Infection Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04864548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*